GIM
AERI

Granahan Investment Management’s Aerie Pharmaceuticals AERI Stock Holding History

Granahan Investment Management’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-707,398
Closed -$5.3M – 183
2022
Q2 		$5.3M Sell
707,398
-881,546
-55% -$6.21M 0.18% 115
2022
Q1 		$14.5M Buy
1,588,944
+350,061
+28% +$2.7M 0.36% 74
2021
Q4 		$8.7M Sell
1,238,883
-155,387
-11% -$1.63M 0.18% 120
2021
Q3 		$15.9M Buy
1,394,270
+6,299
+0.5% +$92.1K 0.3% 86
2021
Q2 		$22.2M Buy
1,387,971
+228,662
+20% +$3.92M 0.41% 58
2021
Q1 		$20.7M Buy
1,159,309
+825,546
+247% +$14.3M 0.44% 53
2020
Q4 		$4.51M Buy
333,763
+232,514
+230% +$2.81M 0.1% 137
2020
Q3 		$1.19M Sell
101,249
-64,245
-39% -$782K 0.04% 166
2020
Q2 		$2.44M Buy
165,494
+47,216
+40% +$698K 0.09% 144
2020
Q1 		$1.6M Sell
118,278
-128,301
-52% -$2.43M 0.09% 148
2019
Q4 		$5.96M Sell
246,579
-6,363
-3% -$132K 0.27% 84
2019
Q3 		$4.86M Buy
252,942
+202,257
+399% +$4.63M 0.27% 88
2019
Q2 		$1.5M Buy
50,685
+16,009
+46% +$617K 0.07% 156
2019
Q1 		$1.65M Sell
34,676
-22,747
-40% -$1M 0.09% 160
2018
Q4 		$2.07M Buy
+57,423
New +$2.69M 0.15% 130

Other funds holding AERI

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
WIC
Water Island Capital New York $1.08B AUM 105.75% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Granahan Investment Management's AERI Position: Q3 2022 in Review

Granahan Investment Management sold out of Aerie Pharmaceuticals (AERI) in Q3 2022, closing a stake of 707,398 shares — an estimated $5.3M sold.

Granahan Investment Management first reported a position in AERI in Q4 2018 and held it in 15 quarters. The position peaked at $22.2M in Q2 2021. 156 funds tracked by Wall St. Rank hold AERI as of Q3 2022.

  • Granahan Investment Management reported no remaining Aerie Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Granahan Investment Management sold 707,398 Aerie Pharmaceuticals shares in Q3 2022, an estimated $5.3M.
  • Granahan Investment Management first reported a position in Aerie Pharmaceuticals in Q4 2018 and held it in 15 quarters.
  • Granahan Investment Management's Aerie Pharmaceuticals position peaked at $22.2M in Q2 2021.
  • 156 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q3 2022.

Based on Granahan Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.